BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34521082)

  • 1. Associations between Combined Influenza and Pneumococcal Pneumonia Vaccination and Cardiovascular Outcomes.
    Ma J; Mena M; Mandania RA; Ghosh A; Dodoo C; Dwivedi AK; Mukherjee D
    Cardiology; 2021; 146(6):772-780. PubMed ID: 34521082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Cardiovascular Protection and Influenza Vaccination.
    Ngwudike CJ; Villalobos A
    Curr Cardiol Rep; 2023 Jun; 25(6):571-576. PubMed ID: 37058200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis.
    Mo Y; Zeng J; Xiao C; Zhang L; Wang L; Lu F; Johnson DW; Stålsby Lundborg C; Nitsch D; Liu X; Su G
    Vaccine; 2020 Nov; 38(47):7422-7432. PubMed ID: 33059969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination in mitigating vascular events and risk.
    Mares AC; Mukherjee D
    Curr Opin Cardiol; 2023 Jul; 38(4):327-330. PubMed ID: 36728725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis.
    Zhang YY; Tang XF; Du CH; Wang BB; Bi ZW; Dong BR
    Hum Vaccin Immunother; 2016 Dec; 12(12):3056-3064. PubMed ID: 27629584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
    Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
    PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.
    Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A; Gomez F; Raga X; de Diego C; Satue E; Salsench E;
    BMC Public Health; 2012 Mar; 12():222. PubMed ID: 22436146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.
    Nichol KL; Baken L; Wuorenma J; Nelson A
    Arch Intern Med; 1999 Nov; 159(20):2437-42. PubMed ID: 10665892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccination and 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and mortality among intensive care unit survivors aged 65 years or older: a nationwide population-based cohort study.
    Christiansen CF; Thomsen RW; Schmidt M; Pedersen L; Sørensen HT
    Intensive Care Med; 2019 Jul; 45(7):957-967. PubMed ID: 31187170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis.
    Gupta C; Sachdeva A; Khamar J; Bu C; Bartoszko J; Loeb M
    Vaccine; 2022 May; 40(25):3433-3443. PubMed ID: 35562195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.
    Simonsen L; Taylor RJ; Young-Xu Y; Haber M; May L; Klugman KP
    mBio; 2011 Jan; 2(1):e00309-10. PubMed ID: 21264063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pneumococcal polysaccharide vaccine on incidence and mortality after pneumonia in adults aged ≥60 years-a population-based retrospective cohort study.
    Kolditz M; Schmitt J; Pletz MW; Tesch F
    Clin Microbiol Infect; 2018 May; 24(5):500-504. PubMed ID: 28830805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis.
    Yin M; Huang L; Zhang Y; Yu N; Xu X; Liang Y; Ni J
    Expert Rev Vaccines; 2018 Jul; 17(7):653-663. PubMed ID: 29961353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.
    Christenson B; Hedlund J; Lundbergh P; Ortqvist A
    Eur Respir J; 2004 Mar; 23(3):363-8. PubMed ID: 15065822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.
    Vamos EP; Pape UJ; Curcin V; Harris MJ; Valabhji J; Majeed A; Millett C
    CMAJ; 2016 Oct; 188(14):E342-E351. PubMed ID: 27455981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions: Experience from the Hunter Community Study.
    Ren S; Holliday E; Hure A; Peel R; Hancock S; Leigh L; Oldmeadow C; Newby D; Li SC; Attia J
    Vaccine; 2018 Nov; 36(49):7520-7524. PubMed ID: 30420042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies.
    Vlachopoulos CV; Terentes-Printzios DG; Aznaouridis KA; Pietri PG; Stefanadis CI
    Eur J Prev Cardiol; 2015 Sep; 22(9):1185-99. PubMed ID: 25252595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza Vaccination as Prevention Therapy for Stable Coronary Artery Disease and Acute Coronary Syndrome: A Meta-Analysis of Randomized Trials.
    Barbetta LMDS; Correia ETO; Gismondi RAOC; Mesquita ET
    Am J Med; 2023 May; 136(5):466-475. PubMed ID: 36809811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.